STRS Ohio’s Maze Therapeutics MAZE Stock Holding History

STRS Ohio’s Portfolio MAZE Stock Details MAZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$188K	Sell	6,300 -4,900	-44%	-$216K	﹤0.01%	1520
2025 Q4	$464K	Sell	11,200 -6,700	-37%	-$230K	﹤0.01%	1137
2025 Q3	$464K	Sell	17,900 -29,000	-62%	-$490K	﹤0.01%	1137
2025 Q2	$575K	Buy	46,900 +45,300	+2,831%	+$471K	﹤0.01%	1168
2025 Q1	$17.6K	Buy	+1,600	New	+$19.3K	﹤0.01%	1856

Other funds holding MAZE

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

STRS Ohio's MAZE Position: Q1 2026 in Review

STRS Ohio reduced its Maze Therapeutics (MAZE) stake by 44% in Q1 2026, selling an estimated $216K and leaving 6,300 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #1520.

STRS Ohio first reported a position in MAZE in Q1 2025 and has held it in 5 quarters since. The position peaked at $575K in Q2 2025. 165 funds tracked by Wall St. Rank hold MAZE as of Q1 2026.

STRS Ohio held 6,300 shares of Maze Therapeutics worth $188K as of Q1 2026.
STRS Ohio sold 4,900 Maze Therapeutics shares in Q1 2026, an estimated $216K.
Maze Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1520 holding.
STRS Ohio first reported a position in Maze Therapeutics in Q1 2025 and has held it in 5 quarters since.
STRS Ohio's Maze Therapeutics position peaked at $575K in Q2 2025.
165 funds tracked by Wall St. Rank held Maze Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.